News
Malaria prevents hospitals from meeting blood demands
On average, blood demand increased about 24% from low transmission season to high transmission season. And some hospitals could not meet the...
News
Study reveals gap in patient blood management
The research showed that 72 US hospitals have made strides in reducing the use of RBCs in patients undergoing orthopedic and cardiac surgery. And...
News
Results support transfusing with caution in TTP, HIT
The research indicated that platelet transfusions may increase the risk of arterial thrombosis and mortality among hospitalized patients with...
News
Transfusions benefit adults with sickle cell disease
Patients had fewer visits to the emergency department (ED) and fewer hospital admissions for pain control after they received chronic transfusions...
News
RECESS suggests RBC age doesn’t affect outcomes
Credit: UAB Hospital PHILADELPHIA—As the medical community continues to debate whether transfusing older blood has a negative outcome on patients...
News
Study supports 2:1 ratio for transfusion in pregnancy
PHILADELPHIA—Results of a single-center study suggest that, when it comes to massive transfusion in pregnancy, a 1:1 ratio of red blood cells (...
News
Residents arrange transfusions despite poor knowledge
On an exam assessing transfusion knowledge, the residents’ mean score was 45.7%. And in a survey, an overwhelming majority of residents said they...
News
Method can detect drivers of AML
PHILADELPHIA—Super-enhancer profiling can unearth biomarkers and therapeutic targets for acute myeloid leukemia (AML), according to research...
News
Antibody gets orphan status for CTCL in Europe
IPH4102 is a cytotoxic anti-KIR3DL2 monoclonal antibody (mAb) that targets CTCL cells. Orphan status provides Innate Pharma, the company...
News
Study validates drug’s efficacy in CLL/SLL
Ibrutinib conferred these benefits irrespective of baseline clinical characteristics or molecular features, including 17p deletion. Atrial...
News
Phase 2 results lead to breakthrough designation
The decision was based on promising results of a phase 2 trial, which were presented at the 50th Annual Meeting of the American Society of...
News
QOL data support ATRA-ATO in APL
Previously released data from a phase 3 study showed that ATRA-ATO can improve survival rates in APL patients when compared to ATRA plus...
News
Thalidomide offers short-term efficacy in HHT
All 29 evaluable patients responded to thalidomide, with 4 achieving a complete response. Unfortunately, 11 patients relapsed at a median of 43...
News
Inhibitor shows promise for hematologic disorders
Photo courtesy of EHA MILAN—The IDH2 inhibitor AG-221 is well-tolerated and exhibits durable clinical activity in patients with hematologic...
News
Studies confirm importance of CALR mutation in PMF
One study showed that PMF patients with mutated CALR had prolonged overall survival (OS) compared to patients with wild-type CALR.